Free Access
Med Sci (Paris)
Volume 25, Number 1, Janvier 2009
Page(s) 51 - 56
Section M/S revues
Published online 15 January 2009
  1. Picot MC, Baldy-Moulinier M, Daures JP, et al. The prevalence of epilepsy and pharmacoresistant epilepsy in adults : A population-based study in a Western European country. Epilepsia 2008; 49 : 1230–8. [Google Scholar]
  2. Schuele SU, Luders HO. Intractable epilepsy : management and therapeutic alternatives. Lancet Neurol 2008; 7 : 514–24. [Google Scholar]
  3. Proposal for revised classification of epilepsies and epileptic syndromes. Commission on classification and terminology of the international league against epilepsy. Epilepsia 1989; 30 : 389–99. [Google Scholar]
  4. French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs I : treatment of new onset epilepsy : report of the therapeutics and technology assessment subcommittee and quality standards subcommittee of the American academy of neurology and the American epilepsy society. Neurology 2004; 62 : 1252–60. [Google Scholar]
  5. Landmark CJ. Targets for antiepileptic drugs in the synapse. Med Sci Monit 2007; 13 : RA1–7. [Google Scholar]
  6. French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs II : treatment of refractory epilepsy : report of the therapeutics and technology assessment subcommittee and quality standards subcommittee of the American academy of neurology and the American epilepsy society. Neurology 2004; 62 : 1261–73. [Google Scholar]
  7. Freeman JM, Vining EP, Pillas DJ, et al. The efficacy of the ketogenic diet-1998 : a prospective evaluation of intervention in 150 children. Pediatrics 1998; 102 : 1358–63. [Google Scholar]
  8. Vining EP, Freeman JM, Ballaban-Gil K, et al. A multicenter study of the efficacy of the ketogenic diet. Arch Neurol 1998; 55 : 1433–7. [Google Scholar]
  9. Kwiterovich PO Jr, Vining EP, Pyzik P, et al. Effect of a high-fat ketogenic diet on plasma levels of lipids, lipoproteins, and apolipoproteins in children. JAMA 2003; 290 : 912–20. [Google Scholar]
  10. Fuehrlein BS, Rutenberg MS, Silver JN, et al. Differential metabolic effects of saturated versus polyunsaturated fats in ketogenic diets. J Clin Endocrinol Metab 2004; 89 : 1641–5. [Google Scholar]
  11. Bough KJ, Rho JM. Anticonvulsant mechanisms of the ketogenic diet. Epilepsia 2007; 48 : 43–58. [Google Scholar]
  12. Tinoco J. Dietary requirements and functions of alpha-linolenic acid in animals. Prog Lipid Res 1982; 21 : 1–45. [Google Scholar]
  13. Bourre JM, Dumont O, Piciotti M, et al. Essentiality of omega 3 fatty acids for brain structure and function. World Rev Nutr Diet 1991; 66 : 103–17. [Google Scholar]
  14. Haag M. Essential fatty acids and the brain. Can J Psychiatry 2003; 48 : 195–203. [Google Scholar]
  15. Yehuda S, Rabinovitz S, Mostofsky DI. Effects of essential fatty acids preparation (SR-3) on brain biochemistery and on behavioral and cognitive functions. In : Yehuda S, Mostofsky DI, eds. Handbook of essential fatty acids biology : biochemistery, physiology and behavioral neurobiology. Totowa, New Jersey : Humana Press, 1997 : 427–52. [Google Scholar]
  16. Xiao Y, Li X. Polyunsaturated fatty acids modify mouse hippocampal neuronal excitability during excitotoxic or convulsant stimulation. Brain Res 1999; 846 : 112–21. [Google Scholar]
  17. Young C, Gean PW, Chiou LC, Shen YZ. Docosahexaenoic acid inhibits synaptic transmission and epileptiform activity in the rat hippocampus. Synapse 2000; 37 : 90–4. [Google Scholar]
  18. Yehuda S, Carasso RL, Mostofsky DI. Essential fatty acid preparation (SR-3) raises the seizure threshold in rats. Eur J Pharmacol 1994; 254 : 193–8. [Google Scholar]
  19. Rabinovitz S, Mostofsky DI, Yehuda S. Anticonvulsant efficiency, behavioral performance and cortisol levels : a comparison of carbamazepine (CBZ) and a fatty acid compound (SR-3). Psychoneuroendocrinology 2004; 29 : 113–24. [Google Scholar]
  20. Taha AY, Baghiu BM, Lui R, et al. Lack of benefit of linoleic and alpha-linolenic polyunsaturated fatty acids on seizure latency, duration, severity or incidence in rats. Epilepsy Res 2006; 71 : 40–6. [Google Scholar]
  21. Voskuyl RA, Vreugdenhil M, Kang JX, Leaf A. Anticonvulsant effect of polyunsaturated fatty acids in rats, using the cortical stimulation model. Eur J Pharmacol 1998; 341 : 145–52. [Google Scholar]
  22. Lauritzen I, Blondeau N, Heurteaux C, et al. Polyunsaturated fatty acids are potent neuroprotectors. EMBO J 2000; 19 : 1784–93. [Google Scholar]
  23. Taha AY, Huot PS, Reza-Lopez S, et al. Seizure resistance in fat-1 transgenic mice endogenously synthesizing high levels of omega-3 polyunsaturated fatty acids. J Neurochem 2008; 105 : 380–8. [Google Scholar]
  24. Porta N, Bourgois B, Galabert C et al. Anticonvulsant effects of linolenic acid are unrelated to brain phospholipid cell membrane compositions. Epilepsia 2008; 22 novembre online. [Google Scholar]
  25. Youdim KA, Martin A, Joseph JA. Essential fatty acids and the brain : possible health implications. Int J Dev Neurosci 2000; 18 : 383–99. [Google Scholar]
  26. Fernstrom JD. Effects of dietary polyunsaturated fatty acids on neuronal function. Lipids 1999; 34 : 161–9. [Google Scholar]
  27. Vreugdenhil M, Bruehl C, Voskuyl RA, et al. Polyunsaturated fatty acids modulate sodium and calcium currents in CA1 neurons. Proc Natl Acad Sci USA 1996; 93 : 12559–63. [Google Scholar]
  28. Xiao YF, Kang JX, Morgan JP, Leaf A. Blocking effects of polyunsaturated fatty acids on Na+ channels of neonatal rat ventricular myocytes. Proc Natl Acad Sci USA 1995; 92 : 11000–4. [Google Scholar]
  29. Xiao YF, Gomez AM, Morgan JP, et al. Suppression of voltage-gated L-type Ca2+ currents by polyunsaturated fatty acids in adult and neonatal rat ventricular myocytes. Proc Natl Acad Sci USA 1997; 94 : 4182–7. [Google Scholar]
  30. Poling JS, Vicini S, Rogawski MA, Salem N Jr. Docosahexaenoic acid block of neuronal voltage-gated K+ channels : subunit selective antagonism by zinc. Neuropharmacology 1996; 35 : 969–82. [Google Scholar]
  31. Keros S, McBain CJ. Arachidonic acid inhibits transient potassium currents and broadens action potentials during electrographic seizures in hippocampal pyramidal and inhibitory interneurons. J Neurosci 1997; 17 : 3476–87. [Google Scholar]
  32. Xu XP, Erichsen D, Borjesson SI, et al. Polyunsaturated fatty acids and cerebrospinal fluid from children on the ketogenic diet open a voltage-gated K channel : a putative mechanism of antiseizure action. Epilepsy Res 2008; 80 : 57–66. [Google Scholar]
  33. Auvin S, Sankar R. Inflammation, epilepsy, and anti-inflammatory therapies. In : Pellock JM, Bourgeois B, Dodson W, Nordli DR Jr, Sankar R, eds. Pediatric epilepsy : diagnosis and therapy. New York : Demos Medical Publishing, 2008. [Google Scholar]
  34. Calder PC. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006; 83 : S1505–19. [Google Scholar]
  35. Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 2002; 21 : 495–505. [Google Scholar]
  36. Gottrand F. Acides gras polyinsaturéset immunité. Arch Pediatr 2007; 14 : 5–7. [Google Scholar]
  37. Schlanger S, Shinitzky M, Yam D. Diet enriched with omega-3 fatty acids alleviates convulsion symptoms in epilepsy patients. Epilepsia 2002; 43 : 103–4. [Google Scholar]
  38. Yuen AW, Sander JW, Fluegel D, et al. Omega-3 fatty acid supplementation in patients with chronic epilepsy : a randomized trial. Epilepsy Behav 2005; 7 : 253–8. [Google Scholar]
  39. Bromfield E, Dworetzky B, Hurwitz S, et al. A randomized trial of polyunsaturated fatty acids for refractory epilepsy. Epilepsy Behav 2008; 12 : 187–90. [Google Scholar]
  40. Spirer Z, Koren L, Finkelstein A, Jurgenson U. Prevention of febrile seizures by dietary supplementation with N-3 polyunsaturated fatty acids. Med Hypotheses 1994; 43 : 43–5. [Google Scholar]
  41. Ruxton CH, Reed SC, Simpson MJ, Millington KJ. The health benefits of omega-3 polyunsaturated fatty acids : a review of the evidence. J Hum Nutr Diet 2007; 20 : 275–85. [Google Scholar]
  42. Bourre JM. Acides gras oméga-3 et troubles psychiatriques. Med Sci (Paris) 2005; 21 : 216–21. [Google Scholar]
  43. Girard C, Lesage F. Canaux K2P neuronaux : aspects moléculaires et fonctionnels. Med Sci (Paris) 2004; 20 : 544–9. [Google Scholar]
  44. Beauchamp E, Rioux V, Legrand P. Acide myristique : nouvelles fonctions de régulation et de signalisation. Med Sci (Paris) 2009; 25 : 57–63. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.